Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0171 per EA under NDC 00904740161. Its NADAC has been published 106 times since Sep 25, 2024.
FDA first approved this application on Sep 26, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904740161
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078643FDA Approved
9/26/2008
TE Code
AB
On Market Since
9/26/2008
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 106 times since Sep 25, 2024, and over the history we have for it it has declined 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0171 per EA |
|---|---|
| All-time high | $0.0198 (Oct 16, 2024) |
| All-time low | $0.0144 (Nov 20, 2024) |
| 52-week high | $0.0190 |
| 52-week low | $0.0169 |
| Median price | $0.0177 |
| Average price | $0.0178 |
| Largest weekly change | -25.1% (Nov 20, 2024) |
| Weeks tracked | 106 |
| Tracking since | Sep 25, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclobenzaprine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0171 per EA (NDC 00904740161), effective Sep 30, 2026.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 13.7%. It has been tracked across 106 weekly CMS publications since Sep 25, 2024.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Sep 25, 2024, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0144 (Nov 20, 2024) to a high of $0.0198 (Oct 16, 2024), with a median of $0.0177 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 00904740161) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.